On July 31, 2025, the Trump administration released “Winning the Race: America’s AI Action Plan.” CSET has broken down the Action Plan, focusing on specific government deliverables. Our Provision and Timeline tracker breaks down which agencies are responsible for implementing recommendations and the types of actions they should take.

Opposing narratives around AI for biotechnology raise the question: how are biotech researchers actually using AI in published research? CSET’s Steph Batalis, Catherine Aiken, and James Dunham explored this question by leveraging CSET’s merged academic corpus, enriched publication metadata, and research clusters.

Artificial intelligence is becoming more integrated into the sciences. One of the scientific fields experiencing this is computational biology, which uses computer modeling to understand biological mechanisms and systems. This blog post provides an understanding of important research trends in these subject areas, and how advancements in AI can improve the speed and efficiency of computational biology to improve human health and well-being.

Now that the first set of milestones has passed for the Biden administration’s October 2023 executive order on artificial intelligence, where do things stand for biotech? This blog post gives an overview of the most recent action items, with a recap of expert commentary from CSET’s June 2024 Webinar on the AIxBio Policy Landscape.

Over the past year, artificial intelligence has quickly become a focal point in K-12 education. This blog post describes new and existing K-12 AI education efforts so that U.S. policymakers and other decision-makers may better understand what’s happening in practice.

The Carnegie Classification of Institutions of Higher Education is making changes to drastically simplify the criteria that determine its highly coveted R1 top-tier research classification. Last year, CSET Senior Fellow, Jaret Riddick, wrote about a new law from Congress, Section 223 of the 2023 National Defense Authorization Act, intended to leverage existing Carnegie classification criteria to increase defense research capacity for historically Black colleges and universities. Now, research is needed to understand how the changes proposed for 2025 classification criteria impact U.S. Department of Defense goals for eligible HBCU partners.

As the U.S. government considers banning genomics companies from China in the Biosecure Act, it opens a broader question of how the U.S. and other market economies should deal with China’s national champions. This blog post provides an overview of BGI and how China’s industrial policy impacts technology development.

This guide provides a run-down of CSET’s research since 2019 for first-time visitors and long-term fans alike. Quickly get up to speed on our “must-read” research and learn about how we organize our work.

The recent Executive Order on the Safe, Secure, and Trustworthy Development and Use of Artificial Intelligence will have major implications for biotechnology. The EO demonstrates that the White House considers biorisk a major concern for AI safety and security. In this blog post CSET’s bio experts explain the bio-relevant takeaways of the executive order, add some additional context, and note their remaining questions about its implementation.

There’s a lot to digest in the October 30 White House’s AI Executive Order. Our tracker is a useful starting point to identify key provisions and monitor the government’s progress against specific milestones, but grappling with the substance is an entirely different matter. This blog post, focusing on Section 4 of the EO (“Developing Guidelines, Standards, and Best Practices for AI Safety and Security”), is the first in a series that summarizes interesting provisions, shares some of our initial reactions, and highlights some of CSET’s research that may help the USG tackle the EO.